Metformin-induced activation of Ca2+ signaling prevents immune infiltration/pathology in Sjogren’s syndrome-prone mouse models is a research paper published in Journal of Translational Autoimmunity (2023). On theSindex it has a DataRank of 0.513. It has been cited 11 times, with 11 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.141
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 11 citers.
National Institute of Dental and Craniofacial Research
Grant: R01DE017102
National Institute of Dental and Craniofacial Research
Grant: R01DE022765
NCI NIH HHS
Grant: P30 CA054174
NCATS NIH HHS
Grant: UL1 TR001120
NIDCR NIH HHS
Grant: R01 DE031716
National Institutes of Health
Grant: 5P30CA054174-16
SAN ANTONIO CANCER INSTITUTE
National Institutes of Health
Grant: 5R01DE017102-03
TRPC1 and saliva secretion
National Institutes of Health
Grant: 5R01DE022765-04
Epigenetic regulations in Sjogern's syndrome
National Institutes of Health
Grant: 3UL1TR001120-02S1
Institute for Integration of Medicine & Science: A Partnership to Improve Health
National Institutes of Health
University of Texas Health Science Center at San Antonio
FWCI
1.54
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals